Purchases and Sales Made in Q4 2021 in Kinnate Biopharma Inc. (KNTE)
This table provides information about the institutional ownership of Kinnate Biopharma Inc. (KNTE) during Q4 2021. The information is specifically focused on institutions that hold shares of Kinnate Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-8.93KClosed |
$147K - $227K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-9.2KClosed |
$152K - $234K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-14.5K- 50.86% |
$239K - $369K
|
14K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
High Vista Strategies LLC
Boston, MA |
SELL
|
- |
-14.6K- 24.04% |
$242K - $373K
|
46.3K
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-23.4KClosed |
$385K - $595K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Alpine Global Management, LLC
New York, NY |
SELL
|
- |
-26KClosed |
$429K - $662K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-32.6K- 2.82% |
$537K - $830K
|
1.12M
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-37.5K- 39.65% |
$619K - $955K
|
57.1K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-42.9K- 4.17% |
$709K - $1.09M
|
986K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-94.3KClosed |
$1.56M - $2.4M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
SELL
|
- |
-367K- 91.17% |
$6.06M - $9.36M
|
35.6K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-700K- 47.52% |
$11.6M - $17.8M
|
773K
$0
|